PARP Inhibitors in Ovarian Cancer: A Society of Gynecologic Oncology Podcast

Gynecologic Oncology by Health Advance

May 8, 202619:50Science & Medicine

Updates in US Food and Drug Administration approvals for poly-ADP-ribose polymerase inhibitors in Ovarian Cancer: A society of gynecologic oncology clinical practice review Moderator: Ursula A. Matulonis, MD; Dana-Farber...

Related Episodes

Continue listening to more episodes from Gynecologic Oncology.

ERAS 2026: Key Updates Every Gynecologic Oncologist Should Know

Jul 31, 2026 - 26:32

Editor's Choice: Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 202...

Beyond the Binary: Unpacking Molecular Diversity in PMMR Endometrial Cancer

Jul 29, 2026 - 25:53

Editor's Choice: Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed...

Cologuard-like test for identification of endometrial cancer through vaginal sampling

May 13, 2026 - 25:41

Editor's Choice: Optimization of methylated DNA markers to rule out endometrial cancer in patients with a...

Home the Same Day? Testing the Limits in Ovarian Cancer Debulking Surgery

Apr 8, 2026 - 18:21

Editor's Choice: Same day discharge after minimally invasive interval debulking surgery in advanced stage...

Recognizing and Managing ADC-Associated Pulmonary Toxicities

Mar 16, 2026 - 29:40

Editor’s Choice: Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clini...

In good SHAPE

Feb 1, 2026 - 23:45

Editor's Choice: Comparative outcomes of simple versus radical hysterectomy in patients with and wit...

ctDNA-Guided PARPi Therapy in Ovarian Cancer

Jan 1, 2026 - 25:21

Editor’s Choice: Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance...

Beyond treatment: The who, why, when, where and what of cancer follow up

Dec 1, 2025 - 28:29

Editor’s Choice: Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring altern...